What is this?
Breast cancer is a
disease where abnormal cells in the breast grow uncontrollably, forming tumors.
If untreated, these tumors can spread throughout the body and become
life-threatening.
The cancer cells
typically originate in the milk ducts or the milk-producing lobules of the
breast. The earliest stage, known as in situ, is not life-threatening and can
often be detected early. However, cancer cells can invade nearby breast tissue,
forming tumors that cause lumps or thickening.
Invasive breast
cancers have the potential to spread to nearby lymph nodes and other organs
(metastasize), which can be life-threatening.
●
Gender:
○
Female
gender is the strongest risk factor for breast cancer.
○
Approximately
99% of breast cancers occur in women, while 0.5–1% occur in men.
○
Treatment
principles for men are the same as for women.
●
Risk-Increasing Factors:
○
Increasing
age
○
Obesity
○
Harmful
use of alcohol
○
Family
history of breast cancer
○
History
of radiation exposure
○
Reproductive
history (age at first menstrual period and first pregnancy)
○
Tobacco
use
○
Postmenopausal
hormone therapy
●
General Statistics:
○
About
half of breast cancers develop in women with no identifiable risk factor other
than gender and age (over 40 years).
○
Most
women diagnosed with breast cancer do not have a known family history of the
disease.
●
Family History:
○
Having
a family history of breast cancer increases the risk.
○
Lack
of a family history does not significantly reduce the risk.
●
Genetic Factors:
○
Certain
inherited gene mutations (e.g., BRCA1, BRCA2, PALB-2) significantly increase
the risk of breast cancer.
○
Women
with these mutations may consider risk-reduction strategies, such as surgical
removal of both breasts or chemoprevention.
Most early-stage
breast cancers have no symptoms, highlighting the importance of early
detection.
●
Breast
lump or thickening, often painless
●
Change
in breast size, shape, or appearance
●
Skin
changes: dimpling, redness, pitting
●
Alterations
in nipple appearance or areola
●
Abnormal
or bloody nipple discharge
Anyone with an
abnormal breast lump should seek medical care, even if it is not painful.
Most breast lumps are
benign, but cancerous lumps are more treatable when small and not spread to
lymph nodes.
●
Breast
cancer can spread to lymph nodes under the arm, even if they can't be felt.
●
It
may eventually spread to other organs like the lungs, liver, brain, and bones,
causing symptoms such as bone pain or headaches.
Treatment:
There are various
treatment options available for breast cancer patients, including:
●
Surgery
●
Radiation
therapy
●
Chemotherapy
●
Hormone
therapy
●
Targeted
therapy
●
Immunotherapy
The majority of
breast cancer patients undergo surgery to remove the cancer.
Types of surgery:
●
Breast-conserving surgery involves removing the
cancer along with some surrounding healthy tissue, while preserving the breast.
If the cancer is close to the chest wall, part of the chest wall lining may
also be removed. This surgery is also known as a lumpectomy, partial mastectomy,
segmental mastectomy, quadrantectomy, or breast-sparing surgery.
●
A total mastectomy, also known as a simple
mastectomy, is a surgical procedure to remove the entire breast affected by
cancer. During this procedure, some of the lymph nodes under the arm may also
be removed and examined for cancer. This can be performed either simultaneously
with the breast surgery or afterwards, through a separate incision.
●
A modified radical mastectomy involves removing the
entire breast affected by cancer, including the nipple, areola (the dark skin
around the nipple), and the overlying skin. Additionally, most of the lymph
nodes under the arm are also removed.
Chemotherapy can be
administered prior to surgery to remove the tumor. When given before surgery,
chemotherapy helps shrink the tumor, thereby reducing the amount of tissue that
needs to be removed. This pre-surgical treatment is known as preoperative
therapy or neoadjuvant therapy.
Radiation therapy is
a cancer treatment that uses high-energy x-rays or other types of radiation to
destroy cancer cells or inhibit their growth. There are two main types of
radiation therapy:
●
External radiation therapy: Utilizes a machine outside the body to
direct radiation towards the cancerous area.
●
Internal radiation therapy: Involves placing a radioactive
substance, sealed in needles, seeds, wires, or catheters, directly into or near
the cancer.
The method of
radiation therapy depends on the type and stage of the cancer. External
radiation therapy is commonly used for treating breast cancer. Internal
radiation therapy with strontium-89, a radionuclide, is employed to alleviate
bone pain caused by breast cancer that has metastasized to the bones.
Strontium-89 is injected into a vein, travels to the bone surfaces, and
releases radiation to kill the cancer cells in the bones.
Chemotherapy
Chemotherapy, often
referred to as chemo, employs drugs to halt the growth of cancer cells by
either killing them or preventing them from dividing. In the case of breast
cancer, chemotherapy is typically systemic, meaning the drugs are either
injected into a vein or taken orally. This allows the drugs to enter the
bloodstream and target cancer cells throughout the entire body.
Hormone therapy, also
known as endocrine therapy, slows or stops the growth of hormone-sensitive
tumors by either blocking the body's ability to produce hormones or interfering
with the hormones' effects on breast cancer cells. Hormones are substances
produced by glands in the body and circulated in the bloodstream. Certain
hormones can stimulate the growth of some cancers. If tests show that cancer
cells have hormone receptors, drugs, surgery, or radiation therapy can be used
to reduce hormone production or block their effects, a process known as ovarian
ablation.
Types of hormone
therapy for breast cancer include:
●
Aromatase
inhibitors (such as anastrozole, letrozole, or exemestane)
●
Fulvestrant
●
Elacestrant
●
Luteinizing
hormone-releasing hormone (LHRH) agonists (such as goserelin or leuprolide)
●
Megestrol
acetate
●
Tamoxifen
Targeted therapy
involves using drugs or other substances to identify and attack specific cancer
cells. Your doctor may recommend biomarker tests to help predict how you might
respond to certain targeted therapy drugs.
Various types of
targeted therapy are used to treat breast cancer.
Monoclonal antibodies are lab-made immune system proteins designed to treat
many diseases, including cancer. As a treatment, these antibodies can attach to
specific targets on cancer cells or other cells that assist in cancer cell
growth. Once attached, the antibodies can kill cancer cells, inhibit their
growth, or prevent them from spreading. Monoclonal antibodies are administered
by infusion and can be used alone or to deliver drugs, toxins, or radioactive
materials directly to cancer cells. They may also be combined with chemotherapy
as adjuvant therapy.
Monoclonal antibodies
used to treat breast cancer include:
●
Margetuximab
●
Pertuzumab
●
Sacituzumab
govitecan
●
Trastuzumab
●
Trastuzumab
deruxtecan
Tyrosine kinase inhibitors block signals necessary for tumor growth and can be used
with other anticancer drugs as adjuvant therapy. Tyrosine kinase inhibitors
used to treat HER2-positive breast cancer include:
●
Lapatinib
●
Neratinib
●
Tucatinib
Cyclin-dependent kinase (CDK) inhibitors block proteins called cyclin-dependent
kinases, which promote cancer cell growth. CDK inhibitors may be combined with
hormone therapy, such as fulvestrant or letrozole, to treat hormone
receptor-positive, HER2-negative breast cancer. CDK inhibitors used to treat
breast cancer include:
●
Abemaciclib
●
Alpelisib
●
Palbociclib
●
Ribociclib
Mammalian target of rapamycin (mTOR) inhibitors block a protein called mTOR, which can
inhibit cancer cell growth and prevent the formation of new blood vessels that
tumors need. mTOR inhibitors used to treat HER2-negative, hormone
receptor-positive breast cancer include:
●
Everolimus
PARP inhibitors block DNA repair, potentially causing cancer cells to die. PARP
inhibitors used to treat HER2-negative breast cancer with BRCA1 or BRCA2
mutations include:
●
Olaparib
●
Talazoparib
Immunotherapy boosts
a person's immune system to help it fight cancer.
Immune checkpoint
inhibitors are a form of immunotherapy used to treat breast cancer. They work by
blocking proteins known as checkpoints, which are produced by certain immune
system cells, such as T cells, and some cancer cells. These checkpoints
normally prevent immune responses from being too strong, but they can also stop
T cells from killing cancer cells. By blocking these checkpoints, T cells can
more effectively destroy cancer cells.
An immune checkpoint
inhibitor used to treat breast cancer is:
●
Pembrolizumab
Pembrolizumab
operates in multiple ways to kill cancer cells and is also considered targeted
therapy because it targets specific changes or substances in cancer cells.
Side-effects of the treatments:
●
Anemia
●
Appetite
loss
●
Bleeding
and bruising (thrombocytopenia)
●
Constipation
●
Delirium
●
Diarrhea
●
Edema
(swelling)
●
Fatigue
●
Fertility
issues (boys and men)
●
Fertility
issues (girls and women)
●
Flu-like
symptoms
●
Hair
loss (alopecia)
●
Infection
and neutropenia
●
Lymphedema
●
Memory
or concentration problems
●
Mouth
and throat problems
●
Nausea
and vomiting
●
Nerve
problems (peripheral neuropathy)
●
Organ-related
inflammation and immunotherapy
●
Pain
●
Sexual
health issues (men)
●
Sexual
health issues (women)
●
Skin
and nail changes
●
Sleep
problems
●
Urinary
and bladder problems
Late side effects include:
Some treatments for
breast cancer can cause side effects that emerge or persist months or years
after the treatment has concluded, known as late effects.
●
Late
effects of radiation therapy are uncommon but may include:
●
Inflammation
of the lung, particularly if chemotherapy is administered simultaneously.
●
Arm
lymphedema, especially when radiation therapy follows lymph node dissection.
For more information, see Lymphedema.
●
An
increased risk of developing breast cancer in the other breast for women
younger than 45 years who receive radiation therapy to the chest wall after a
mastectomy.
Late effects of
chemotherapy vary depending on the drugs used, but may include:
●
Heart
failure
●
Blood
clots
●
Premature
menopause
●
A
second cancer, such as leukemia
Late effects of
targeted therapy with trastuzumab, lapatinib, or pertuzumab may include:
●
Heart
problems, such as heart failure
Prevention:
Various approaches to
cancer prevention are being researched, including: